NCT07788534 This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.
| NCT ID | NCT07788534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Faisal Specialist Hospital & Research Center |
| Condition | Asthma Childhood |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-11-12 |
| Primary Completion | 2026-11-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-11-12 with a primary completion date of 2026-11-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO
Eligibility Criteria
Inclusion Criteria: * Children aged 6 to 14 years with a physician-diagnosed asthma. * Minimum of three months' follow-up at the pediatric respiratory clinic. * Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data Exclusion Criteria: * Presence of other chronic pulmonary diseases (e.g., cystic fibrosis). * Recent respiratory infections within four weeks prior to enrollment. * Current treatment with biologic agents affecting asthma inflammation.
Contact & Investigator
Nariman Alrabie
PRINCIPAL INVESTIGATOR
king Faisal specialized hospital and research center
Frequently Asked Questions
Who can join the NCT07788534 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 14 Years, studying Asthma Childhood. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07788534 currently recruiting?
Yes, NCT07788534 is actively recruiting participants. Contact the research team at abarnawi1@kfshrc.edu.sa for enrollment information.
Where is the NCT07788534 trial being conducted?
This trial is being conducted at Jeddah, Saudi Arabia, Jeddah, Saudi Arabia.
Who is sponsoring the NCT07788534 clinical trial?
NCT07788534 is sponsored by King Faisal Specialist Hospital & Research Center. The principal investigator is Nariman Alrabie at king Faisal specialized hospital and research center. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.